Stay updated on Atezolizumab in Esophageal Cancer: Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab in Esophageal Cancer: Clinical Trial page.

Latest updates to the Atezolizumab in Esophageal Cancer: Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA site interface revision indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check16 days agoChange DetectedAdded three new trial sites: Goztepe Prof.Dr. Suleyman Yalcin City Hospital (Kadiköy, Turkey), The First St.Petersburg State Medical University (Saint Petersburg, Russia), and Scientific Research Institute n.a. N.N. Petrov (Saint Petersburg, Russia); removed New Cross Hospital (Wolverhampton, UK). The total number of locations increased from 165 to 167.SummaryDifference0.3%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedPadua, Veneto, Italy, 35128 was replaced with Padova, Veneto, Italy, 35128; the Padua listing was removed and Padova added.SummaryDifference0.0%

- Check38 days agoChange DetectedNapoli, Campania, Italy, 80131 in the Locations list was replaced with Naples, Campania, Italy, 80131. The page revision tag changed from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check59 days agoChange DetectedAdded Revision: v3.4.3; removed Revision: v3.4.2.SummaryDifference0.0%

- Check81 days agoChange DetectedRevision: v3.4.2 has been added and Revision: v3.4.1 removed as a minor update to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Atezolizumab in Esophageal Cancer: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab in Esophageal Cancer: Clinical Trial page.